Not Verified

POSTDOCTORAL AND CLINICAL RESEARCH FELLOW GRANT

Rally Foundation for Childhood Cancer Research

The application must address at least one of the following priority areas related to cancer in children, adolescents and/or young adults up to age 24 (see Section V. Grants for age ranges):

• Innovative approaches to research that could lead to advanced studies, better delivery of treatment or clinical translation.

• Basic science studies that are likely to lead to a new discovery.

• Under-studied cancer types.

• Quality of life, survivorship and palliative care studies.

• Personalized, targeted, alternative or integrative research proposals.

• Data utilization through data standardization, collection, storage, analysis and sharing. The following will not be reviewed:

• Proposals that have no direct relevance to pediatric cancer nor fall within the scope of A Collaborative Pediatric Cancer Research Awards Program.

• Proposals for infrastructure programs.

• Incomplete applications and/or applications received after the application deadline.

Award Amount

Postdoctoral and Clinical Research Fellow Grants up to $50,000 per year for one or two years of support will be awarded. Please note that not all applicants that request two years of funding are awarded two years of support. Awards are determined by a competitive peer-review process and scores received. One-year grants will receive two installments, and two-year grants will receive four installments, one every six months. Grants awarded one year of funding will have the option to apply for a second year of support with a bypass of the Letter of Intent and the submission of a Postdoctoral and Clinical Research Fellow Grant Renewal. Grant Renewal applications will be peer-reviewed and considered with all other applications in the grant cycle.

The Collaborative Organizations have an interest in funding postdoctoral and clinical research fellows. A portion of available funds are reserved for Postdoctoral and Clinical Research Fellow Grants contingent on scores received.

AI Based Application Success Predictor

1. Direct relevance to childhood cancer ⭐⭐⭐⭐⭐

This is the most important eligibility and success factor.

The proposed research must have direct relevance to cancer in children, adolescents, and/or young adults. Applications without direct pediatric-cancer relevance are not reviewed.

Relevant areas include:

Pediatric solid tumors
Pediatric brain tumors
Leukemias
Sarcomas
Neuroblastoma
Rhabdomyosarcoma
Osteosarcoma
Wilms tumor
Diffuse midline glioma
Medulloblastoma
Childhood cancer survivorship

2. Innovation and breakthrough potential ⭐⭐⭐⭐⭐

Rally strongly emphasizes innovative and promising research.

Competitive projects should introduce:

Novel scientific concepts
New therapeutic approaches
New diagnostic strategies
Innovative technologies
New disease models
New treatment-delivery approaches
Potentially transformative ideas

Rally describes its research strategy as funding bold, early-stage research with the greatest potential to save lives.

3. Potential to develop better and safer treatments ⭐⭐⭐⭐⭐

A particularly strong application explains how the research could lead to:

More effective treatments
Reduced treatment toxicity
Fewer long-term side effects
Better treatment delivery
Improved clinical trials
New therapeutic targets
Ultimately, cures

Rally specifically states that its mission is to help develop better childhood cancer treatments with fewer long-term side effects and ultimately cures.

4. Strong scientific rationale and methodology ⭐⭐⭐⭐⭐

Because Rally uses a competitive dual peer-review process conducted by its Medical Advisory Board, scientific quality is critical. The Board consists of leading pediatric cancer experts.

Strong proposals should demonstrate:

Clear hypothesis
Well-defined aims
Strong preliminary rationale where appropriate
Appropriate experimental design
Appropriate controls
Statistical rigor
Feasible methodology
Realistic timeline

5. Translational potential ⭐⭐⭐⭐⭐

Rally funds research from bench science to translational research and specifically prioritizes innovative approaches that could lead to advanced studies, improved treatment delivery, or clinical trials.

A strong proposal should therefore establish a pathway such as:

Basic discovery → validation → preclinical evidence → clinical translation → improved pediatric treatment

6. Addressing under-studied childhood cancers ⭐⭐⭐⭐⭐

Rally explicitly lists under-studied cancer types as a priority area.

Projects addressing cancers where:

Research funding is limited
Treatment options are inadequate
Survival remains poor
Disease biology is poorly understood
Existing therapies have substantial toxicity

may therefore have particularly strong alignment.

For the 2027 collaborative cycle, designated funding is available for rhabdomyosarcoma, sarcomas, Wilms tumor, AML, diffuse midline glioma, neuroblastoma, and medulloblastoma.

7. Personalized and targeted treatment approaches ⭐⭐⭐⭐⭐

Rally explicitly supports:

Personalized medicine
Targeted therapies
Alternative approaches
Integrative approaches

Strong proposals should demonstrate why the approach could improve treatment selection or produce better outcomes for specific pediatric cancer populations.

8. Quality of life, survivorship and palliative care ⭐⭐⭐⭐☆

Rally does not focus exclusively on curing cancer.

Its published priority areas also include:

Quality of life
Survivorship
Palliative care
Long-term treatment effects
Reducing treatment burden

Thus, projects that improve the lives of children during and after cancer treatment can fit the Foundation's priorities.

9. Data utilization and collaboration ⭐⭐⭐⭐☆

Rally specifically identifies data standardization, collection, storage, analysis, and sharing as a research priority.

Collaborative projects can be especially compelling when multiple institutions contribute complementary expertise.

The Consortium Grant requires at least three institutions, with each institution making a unique contribution.

10. Investigator potential and career development ⭐⭐⭐⭐⭐

Rally has a strong commitment to developing the next generation of pediatric cancer researchers.

Its portfolio includes:

Postdoctoral/Clinical Research Fellow Grants
Young Investigator Grants
Career Development Awards
Independent Investigator Grants
Consortium Grants

The Career Development Award specifically supports investigators in their first independent faculty appointment, providing protected research time and funding to help them transition from mentorship to research independence.

Specialties

Cancer

Pediatrics

Eligibility Requirements

• Applicants conducting pediatric cancer research as a clinical fellow in pediatric hematology/oncology and/or postdoctoral research fellow.

• Applicants must hold at least an M.D., D.O., Pharm.D. or Ph.D. degree and be conducting research after the first year of their fellowship.

• Applicants in the last year of their fellowship are only eligible for a one-year grant. They may re-apply for an Independent Investigator Grant as a young investigator in the following grant cycle. To determine whether to apply for a Postdoctoral and Clinical Research Fellow Grant or an Independent Investigator Grant, consider your anticipated position as of the start of the award period.

• Applicants do not need to be U.S. citizens or located at a U.S. institution.

• The applicant’s institution may be a hospital, university or private lab.

Sponsor Details

Sponsor Institute/Organizations: Rally Foundation for Childhood Cancer Research

Sponsor Type: Corporate/Non-Profit

Address: 5775 Glenridge Drive Building B, Suite 370 Atlanta, GA 30328 404-847-1270

Legal & Affiliation Disclaimer

Affiliation Disclaimer: Trialect operates independently and is not affiliated with, endorsed by, or supported by any sponsors or organizations posting on the GrantsBoard platform. As an independent aggregator of publicly available funding opportunities, Trialect provides equal access to information for all users without endorsing any specific funding source, content, organization, or sponsor. Trialect assumes no responsibility for the content posted by sponsors or third parties.

Subscription Disclaimer: Upon logging into Trialect, you may choose to SUBSCRIBE to GrantsBoard for timely notifications of funding opportunities and to access exclusive benefits, such as priority alerts, reminders, personalized recommendations, and additional application support. However, users are advised to contact sponsors directly for any questions and are not required to subscribe to engage with funding opportunities.

Content Ownership and Copyright Disclaimer: Trialect respects the intellectual property rights of all organizations and individuals. All content posted on GrantsBoard is provided solely for informational purposes and remains the property of the original owners. Trialect does not claim ownership of, nor does it have any proprietary interest in, content provided by third-party sponsors. Users are encouraged to verify content and ownership directly with the posting sponsor.

Fair Use Disclaimer: The information and content available on GrantsBoard are compiled from publicly accessible sources in alignment with fair use principles under U.S. copyright law. Trialect serves as an aggregator of this content, offering it to users in good faith and with the understanding that it is available for public dissemination. Any organization or individual who believes their intellectual property rights have been violated is encouraged to contact us for prompt resolution.

Third-Party Posting Responsibility Disclaimer: Trialect is a neutral platform that allows third-party sponsors to post funding opportunities for informational purposes only. Sponsors are solely responsible for ensuring that their postings comply with copyright, trademark, and other intellectual property laws. Trialect assumes no liability for any copyright or intellectual property infringements in third-party content and will take appropriate action to address any substantiated claims.

Accuracy and Verification Disclaimer: Trialect makes no warranties regarding the accuracy, completeness, or reliability of the information provided by sponsors. Users are advised to verify the details of any funding opportunity directly with the sponsor before taking action. Trialect cannot be held liable for any discrepancies, omissions, or inaccuracies in third-party postings.

Notice and Takedown Policy: Trialect is committed to upholding copyright law and protecting the rights of intellectual property owners. If you believe that content on GrantsBoard infringes your copyright or intellectual property rights, please contact us with detailed information about the claim. Upon receipt of a valid notice, Trialect will promptly investigate and, where appropriate, remove or disable access to the infringing content.

View Funding Opportunity